NCT05622136View on ClinicalTrials.gov

Dose-escalation of Regorafenib in Advanced Hepatocellular Carcinoma

PHASE2RecruitingINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

September 10, 2023

Primary Completion Date

January 31, 2025

Study Completion Date

June 30, 2025

Conditions
Liver CancerHepatocellular Carcinoma
Interventions
DRUG

Regorafenib Oral Product

Dose escalation strategy

Trial Locations (1)

01246-000

RECRUITING

ICESP - Instituto do Câncer do Estado de São Paulo, São Paulo

All Listed Sponsors
lead

Instituto do Cancer do Estado de São Paulo

OTHER